How effective are the company's research and development efforts in relation to its size? - Philip Fisher
Back on Oct. 24, 2017, Mirati Therapeutics (MRTX) exchanged hands at $5.20 when I first featured it in an expert interview. The stock continues its mega climb over the years. As of yesterday's trading session, Mirati shares stood at the staggering $95.97. Altogether, this Philip Fisher's growth stock garnered strong profits for IBI members.
As you can see, there are mega returns in bioscience investment. But you have to be hungry and aggressive in searching